Venturepharm Group, which Listed in HK Stock Market, Venturepharm is a global leading full service provider of API, PDS, CRO, IDL, CMO, Marketing & Sales services to pharmaceutical and biotechnology companies in China market and beyond.
Driven by the powerful R&D capability with a force of over 300 international scientists and an global extensive network, the company has over 400 non-patent infringed products approved, pending or under development and 6 NCEs before clinical stages as well as over 200 APIs and key intermediates. The company has established client network covering North America, Europe, Africa and Asia.
the company has established 8 R&D centers, 3 GMP integrated manufacture facilities and 4 bulk API manufacturing facilities, two of them are approved & USFDA inspected.
|
|
|
Home -> Company Directory -> Venturepharm Group
